-
InnoCare and Keymed Jointly Announce First Subject Dosed in Clinical Trial of CCR8 Monoclonal Antibody ICP-B05
Market news
PharmaSourcesFebruary 24, 2023
InnoCare Pharma and Keymed Biosciences that the first subject has been dosed in clinical trial of ICP-B05.
-
Malaysian Genomics to Offer World's First DNA-Driven Fertility Test
Market news
PharmasourcesFebruary 24, 2023
Group in strategic collaboration with Divine Genes to offer genetic tests related to reproductive health in Malaysia and overseas.
-
CPHI China opens for international partnering after China rises in CPHI Index
Market news
PharmaSources.comJune 08, 2022
CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see increases in all categories of the most recent CPHI Pharma Index.
-
ProBioGen Launches Their Lentivirus Packaging Cell Line Lenti.RiGHT - A Shortcut to Successful Lentivirus Manufacturing
Market news
PharmaSourcesMay 18, 2023
May 17, 2023，ProBioGen announced the launch of their lentivirus (LV) packaging cell line Lenti.RiGHT as a new platinum standard for LV production at this year's PEGS Boston 2023.
-
SeraNovo and AstraZeneca to Collaborate on Research Projects
Market news
PharmaSourcesMay 16, 2023
SeraNovo is pleased to announce the closing of a multi-compound deal with AstraZeneca.SeraNovo (Leiden, The Netherlands) is pleased to announce the closing of a multi-compound deal with AstraZeneca.
-
High Demand: Vetter Expands Production Capacities and Services Offered at Its Austrian Site
Market news
PharmaSourcesMay 10, 2023
Vetter has completed the first year of production in Rankweil successfully and is preparing to further increase production capacities and capabilities on site.
-
Interpharma Investments Limited Appoints Alfonso "Chito" Zulueta As Non-Executive Chairman
Market news
PharmaSourcesMay 06, 2023
Interpharma Investments Limited, holding company of leading healthcare services provider Zuellig Pharma, today announced the appointment of Mr. Alfonso “Chito” Zulueta as Non-Executive Chairman of its Board.
-
ProBioGen and ImmunOs Therapeutics Team Up to Deliver Innovative Therapy for Cancer Patients
Market news
PharmaSourcesMay 05, 2023
April 12, 2023，ProBioGen and ImmunOs Therapeutics announce the extension of their partnership for further large-scale manufacturing of clinical material for IOS-1002.
-
Nouscom Reaches Clinical Phase II Using ProBioGen’s AGE1.CR.pIX Production Platform
Market news
PharmaSourcesMay 05, 2023
May 04, 2023，ProBioGen announces that their proprietary vaccine production cell line AGE1.CR.pIX has been successfully used to manufacture a viral vector product that has advanced into a randomized phase II clinical trial.
-
Clinical Study Result of Orelabrutinib in Patients with R/R MCL Published by Blood Advances
Market news
PharmaSourcesMay 04, 2023
Blood Advances recently published the clinical study study result of BTK inhibitor orelabrutinib in Relapsed or Refractory Mantle Cell Lymphoma patients.
InnoCare Pharma and Keymed Biosciences that the first subject has been dosed in clinical trial of ICP-B05.
Group in strategic collaboration with Divine Genes to offer genetic tests related to reproductive health in Malaysia and overseas.
CPHI & P-MEC China opens its online international partnering platform as pharmaceutical and biopharmaceutical industries in the country report strong underlying conditions and see increases in all categories of the most recent CPHI Pharma Index.
May 17, 2023，ProBioGen announced the launch of their lentivirus (LV) packaging cell line Lenti.RiGHT as a new platinum standard for LV production at this year's PEGS Boston 2023.
SeraNovo is pleased to announce the closing of a multi-compound deal with AstraZeneca.SeraNovo (Leiden, The Netherlands) is pleased to announce the closing of a multi-compound deal with AstraZeneca.
Vetter has completed the first year of production in Rankweil successfully and is preparing to further increase production capacities and capabilities on site.
Interpharma Investments Limited, holding company of leading healthcare services provider Zuellig Pharma, today announced the appointment of Mr. Alfonso “Chito” Zulueta as Non-Executive Chairman of its Board.
April 12, 2023，ProBioGen and ImmunOs Therapeutics announce the extension of their partnership for further large-scale manufacturing of clinical material for IOS-1002.
May 04, 2023，ProBioGen announces that their proprietary vaccine production cell line AGE1.CR.pIX has been successfully used to manufacture a viral vector product that has advanced into a randomized phase II clinical trial.
Blood Advances recently published the clinical study study result of BTK inhibitor orelabrutinib in Relapsed or Refractory Mantle Cell Lymphoma patients.
Pharma Sources Insight APRIL 2023
